Health / Medical Topics

    Fas Receptor Agonist APO010

    A recombinant, soluble, hexameric fusion protein consisting of three human Fas ligand (FasL) extracellular domains fused to the dimer-forming collagen domain of human adiponectin with potential pro-apoptotic and antineoplastic activities. Assembled into a soluble hexameric structure mimicking the ligand clustering of endogenous active FasL, Fas receptor agonist APO010 activates the Fas receptor, resulting in caspase-dependent apoptosis in susceptible tumor cell populations. FasL is a transmembrane protein of the tumor necrosis factor (TNF) superfamily and a pro-apoptotic ligand for the death receptor Fas. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    This gene is involved in the mediation of cellular surface receptors and apoptotic signals.
    Lymphoproliferative disease of spleen and nodes, no apoptosis, medium sized lymphocytes
    A drug used with bortezomib and dexamethasone to treat multiple myeloma. It is used in patients who have already been treated with…
    Human FARSB wild-type allele is located 2q36.1 and is approximately 86 kb in length. This allele, which encodes phenylalanyl-tRNA synthetase beta chain…
    This gene plays a role in the biosynthesis of amino acids.
    A daloxate ester prodrug form of faropenem, a penem with a tetrahydrofuran substituent at position C2, with broad-spectrum antibacterial activity against many…

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact